News &
Publications

Contacts

Lisa Bailey
Interim Director of Communications
Director of Social Networking
215-214-3954
215-872-5846 (cell phone)
Lisa.Bailey@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Your Heritage Might Save a Life; Minority Marrow Donors Urgently Needed

PHILADELPHIA (October 27, 2000) -- Each year in the Philadelphia region, hundreds of African Americans and Hispanics are diagnosed with leukemia, aplastic anemia or other life-threatening diseases. For many, their only chance for survival is a marrow or blood stem cell transplant often from an unrelated donor.

The Fox Chase-Temple Bone Marrow Transplant (BMT) Program invites you to join the National Marrow Donor Program Registry. A simple blood test is all that is needed to join the Registry. All donor expenses are paid for by the patient. The initial blood test for minorities is paid for by the National Marrow Donor Program.

"Most of the patients on the transplant waiting list here in the Philadelphia region are either Hispanic or African American," said Kenneth F. Mangan, director of the Fox Chase-Temple BMT Program. "The most likely donor for them is someone from his or her racial or ethnic group."

For more information about becoming a donor, please call the American Red Cross at 215-451-4339.� You can also contact the National Marrow Donor Program (NMDP) at 1-800-MARROW-2. Ask for the brochure "Hispanics Giving Hope" or "African Americans Uniting for Life." You can also visit the NMDP online at www.themarrowfoundation.org.

The Fox Chase-Temple BMT Program is part of an academic and clinical affiliation formed by Fox Chase Cancer Center and Temple University in 1998. Since the inception of Temple's BMT program 12 years ago, doctors have performed 532 transplants. For more information or to contact the Fox Chase-Temple BMT Program, please call 215-214-3100.

Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Media inquiries only, please contact Diana Quattrone at 215-728-7784.

More 2000 News Releases »